| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia CM Lewis, DF Levinson, LH Wise, LE DeLisi, RE Straub, I Hovatta, ... The American Journal of Human Genetics 73 (1), 34-48, 2003 | 1466 | 2003 |
| Asynchronous carbon sink saturation in African and Amazonian tropical forests W Hubau, SL Lewis, OL Phillips, K Affum-Baffoe, H Beeckman, ... Nature 579 (7797), 80-87, 2020 | 647 | 2020 |
| An international two–stage genome–wide search for schizophrenia susceptibility genes HW Moises, L Yang, H Kristbjarnarson, C Wiese, W Byerley, F Macciardi, ... Nature genetics 11 (3), 321-324, 1995 | 485 | 1995 |
| The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia HW Moises, T Zoega, II Gottesman BMC psychiatry 2, 1-14, 2002 | 200 | 2002 |
| Antidepressants and public health in Iceland: time series analysis of national data T Helgason, H Tómasson, T Zoega The British Journal of Psychiatry 184 (2), 157-162, 2004 | 173 | 2004 |
| Possible association of a cholecystokinin promotor polymorphism (CCK‐36CT) with panic disorder Z Wang, J Valdes, R Noyes, T Zoega, RR Crowe American journal of medical genetics 81 (3), 228-234, 1998 | 125 | 1998 |
| Candidate gene study of eight GABAA receptor subunits in panic disorder RR Crowe, Z Wang, R Noyes Jr, BE Albrecht, MG Darlison, MES Bailey, ... American Journal of Psychiatry 154 (8), 1096-1100, 1997 | 71 | 1997 |
| No evidence of linkage between schizophrenia and D3 dopamine receptor gene locus in Icelandic pedigrees C Wiese, L Lannfelt, H Kristbjarnarson, L Yang, T Zoega, P Sokoloff, ... Psychiatry research 46 (1), 69-78, 1993 | 66 | 1993 |
| Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder T Kato, ZW Wang, T Zoega, RR Crowe American journal of medical genetics 67 (4), 401-405, 1996 | 55 | 1996 |
| Excluding linkage between panic disorder and the gamma‐aminobutyric acid beta 1 receptor locus in five Icelandic pedigrees SM Schmidt, T Zoega, RR Crowe Acta Psychiatrica Scandinavica 88 (4), 225-228, 1993 | 36 | 1993 |
| Heilsutengd lífsgæði sjúklinga fyrir og eftir meðferð T Helgason, JK Björnsson, K Tómasson, E Grétarsdóttir, H Jónsson, ... Læknablaðið 86, 682-8, 2000 | 20 | 2000 |
| Kvíði, greining og meðferð T Zoëga Geðvernd, 2001 | 17 | 2001 |
| Skimun fyrir algengi geðraskana 1984 og 2002 og ávísanir geðlyfja 1984 og 2001 T Helgason, K Tómasson, E Sigfússon, T Zoega Læknablaðið 90, 553-9, 2004 | 14 | 2004 |
| Algengi og dreifing notkunar geðdeyfðar-, kvíða-og svefnlyfja T Helgason, K Tómasson, T Zoega Læknablaðið, 2003 | 14 | 2003 |
| Epidemiology of psychotropic medication use: comparison of sales, prescriptions and survey data in Iceland K Tomasson, H Tomasson, T Zoega, E Sigfusson, T Helgason Nordic journal of psychiatry 61 (6), 471-478, 2007 | 13 | 2007 |
| The Icelandic health sector database: deCode and the" new" ethics for genetic research T Zoëga | 13 | 2000 |
| Psychiatric emergency clinics in Iceland 1983 S Skúlason, T Zoëga, H Pétursson Nordisk Psykiatrisk Tidsskrift 39 (4), 247-252, 1985 | 12 | 1985 |
| Af hverju fjölgar öryrkjum með geðraskanir?[ritstjórnargrein] T Zoëga Læknafélag Íslands, Læknafélag Reykjavíkur, 2007 | 8 | 2007 |
| Prediction of compliance with medication and follow-up appointments T Zoëga, C Barr, A Barsky Nordisk Psykiatrisk Tidsskrift 45 (1), 27-32, 1991 | 8 | 1991 |
| Psychopharmacoepidemiology in Iceland: effects of regulations and new medications T Helgason, JK Björnsson, T Zoëga, HS Thorsteinsson, H Tómasson European archives of psychiatry and clinical neuroscience 247, 93-99, 1997 | 7 | 1997 |
Kristinn TómassonLækning, Medical center, Lágmúla 5, Reykjavik, IcelandEmail confirmado em laekning.is
